DDInter1811 DDInter1435
A nitroimidazole antitrichomonal agent effective against _Trichomonas vaginalis_, _Entamoeba histolytica_, and _Giardia lamblia_ infections.
Pexidartinib is a selective tyrosine kinase inhibitor that works by inhibiting the colony-stimulating factor (CSF1)/CSF1 receptor pathway. Pexidartinib was originally developed by Daiichi Sankyo, Inc. and it was approved by the FDA in August 2019 as the first systemic therapy for adult patients with symptomatic tenosynovial giant cell tumor. Tenosynovial giant cell tumor is a rare form of non-malignant tumor that causes the synovium and tendon sheaths to thicken and overgrow, leading to damage in surrounding joint tissue.[A182240,L7901] Debilitating symptoms often follow with tenosynovial giant cell tumors, along with a risk of significant functional limitations and a reduced quality of life in patients. While surgical resection is a current standard of care for tenosynovial giant cell tumor, there are tumor types where surgeries are deemed clinically ineffective with a high risk of lifetime recurrence. Pexidartinib works by blocking the immune responses that are activated in tenosynovial giant cell tumors. In clinical trials, pexidartinib was shown to promote improvements in patient symptoms and functional outcomes in TGCT. Pexidartinib is available in oral formulations and it is commonly marketed as Turalio.
Tinidazole {u} (Compound) resembles {v} (Compound) Metronidazole
Tinidazole {u} (Compound) binds {v} (Gene) CYP3A4
Tinidazole {u} (Compound) upregulates {v} (Gene) FOXO4
Tinidazole {u} (Compound) is included by {v} (Pharmacologic Class) Nitroimidazoles
Tinidazole {u} (Compound) downregulates {v} (Gene) IGFBP2
Tinidazole {u} (Compound) causes {v} (Side Effect) Stevens-Johnson syndrome
Tinidazole {u} may cause a minor interaction that can limit clinical effects when taken with {v} Cimetidine
Tinidazole {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ethambutol
Tinidazole {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cabazitaxel
Tinidazole {u} may lead to a major life threatening interaction when taken with {v} Amprenavir
Tinidazole (Compound) resembles Metronidazole (Compound)
Tinidazole (Compound) binds CYP3A4 (Gene)
Tinidazole (Compound) upregulates FOXO4 (Gene)
Tinidazole (Compound) is included by Nitroimidazoles (Pharmacologic Class)
Tinidazole (Compound) downregulates IGFBP2 (Gene)
Tinidazole (Compound) causes Stevens-Johnson syndrome (Side Effect)
Tinidazole may cause a minor interaction that can limit clinical effects when taken with Cimetidine
Tinidazole may cause a moderate interaction that could exacerbate diseases when taken with Ethambutol
Tinidazole may cause a moderate interaction that could exacerbate diseases when taken with Cabazitaxel
Tinidazole may lead to a major life threatening interaction when taken with Amprenavir